EA201070568A1 - Фармацевтические составы - Google Patents

Фармацевтические составы

Info

Publication number
EA201070568A1
EA201070568A1 EA201070568A EA201070568A EA201070568A1 EA 201070568 A1 EA201070568 A1 EA 201070568A1 EA 201070568 A EA201070568 A EA 201070568A EA 201070568 A EA201070568 A EA 201070568A EA 201070568 A1 EA201070568 A1 EA 201070568A1
Authority
EA
Eurasian Patent Office
Prior art keywords
drug
pharmaceutical compositions
component
constituents
solid
Prior art date
Application number
EA201070568A
Other languages
English (en)
Inventor
Эдриан Браун
Ли Дж. Горриндж
Уэйн М. Мэтьюз
Стефен Марк Макаллистер
Дэниель Женевьев Ребекка Расселл
Original Assignee
Глэксо Груп Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Глэксо Груп Лимитед filed Critical Глэксо Груп Лимитед
Publication of EA201070568A1 publication Critical patent/EA201070568A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

Настоящее изобретение относится к новым фармацевтически приемлемым полимерным композициям, применяемым для экструзии из расплава и литьевого формования однокомпонентных или многокомпонентных фармацевтических лекарственных форм, включающих множество содержащих лекарственное вещество составных частей, которые являются секциями в капсуле и/или твердыми составными частями, включающими твердую матрицу из полимера, которая содержит лекарственное вещество, при этом составляющие части соединены вместе в скомпонованную лекарственную форму.
EA201070568A 2007-11-08 2008-11-07 Фармацевтические составы EA201070568A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98638307P 2007-11-08 2007-11-08
PCT/IB2008/003872 WO2009087483A2 (en) 2007-11-08 2008-11-07 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
EA201070568A1 true EA201070568A1 (ru) 2010-12-30

Family

ID=40721919

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201070568A EA201070568A1 (ru) 2007-11-08 2008-11-07 Фармацевтические составы

Country Status (12)

Country Link
US (2) US20110117190A1 (ru)
EP (1) EP2219624A2 (ru)
JP (1) JP2011503048A (ru)
KR (1) KR20100096141A (ru)
CN (1) CN101917978A (ru)
AU (1) AU2008346205B2 (ru)
BR (1) BRPI0820381A2 (ru)
CA (1) CA2705285A1 (ru)
EA (1) EA201070568A1 (ru)
MX (1) MX2010005092A (ru)
TW (1) TW200936186A (ru)
WO (1) WO2009087483A2 (ru)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7842308B2 (en) * 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
US7883721B2 (en) * 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
MY142179A (en) * 2002-07-25 2010-10-15 Glaxo Group Ltd Multicomponent pharmaceutical dosage form
TW200526274A (en) * 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
AR048033A1 (es) * 2004-03-12 2006-03-22 Smithkline Beecham Plc Composicion farmaceutica para moldear componentes que comprende copolimero de poli(met)acrilato, cubierta, conector o espaciador de capsula moldeado por inyeccion que tiene la composicion farmaceutica y forma de dosificacion farmaceutica de multicomponentes a partir de dicha composicion
EP2219583B1 (en) * 2007-10-15 2012-11-21 Capsugel Belgium NV Method and apparatus for manufacturing filled linkers
CN101827572A (zh) * 2007-10-15 2010-09-08 葛兰素集团有限公司 用于释放药物组合物的有板条的胶囊壳
EP2537506A1 (en) * 2007-10-15 2012-12-26 Capsugel Belgium NV Linkers for multipart dosage forms for release of one or more parmaceutical compositions, and the resulting dosage forms
EP2219624A2 (en) * 2007-11-08 2010-08-25 Glaxo Group Limited Pharmaceutical formulations
JP2012502883A (ja) * 2008-06-13 2012-02-02 グラクソ グループ リミテッド 医薬製剤
DE102008031426B4 (de) * 2008-07-04 2014-07-31 Schott Ag Verfahren zur Herstellung einer Versiegelungsschicht für Dekorschichten, Glas- oder Glaskeramik-Artikel und dessen Verwendung
DE102008031428A1 (de) * 2008-07-04 2010-01-07 Schott Ag Dekorative Beschichtung von Glas- oder Glaskeramik-Artikeln
GB201010083D0 (en) * 2010-06-16 2010-07-21 Univ Bradford Compositions and methods
US20120251588A1 (en) * 2011-03-30 2012-10-04 Miyuki Fukasawa Coating Composition, Solid Preparation Coated Therewith, and Method for Preparing Solid Preparation
BR112014003386A2 (pt) * 2011-10-12 2017-03-01 Dow Global Technologies Llc envoltório de uma forma de dosagem moldado por injeção, forma de dosagem e método para produzir um envoltório de uma forma de dosagem
EP4035683A1 (en) * 2011-12-12 2022-08-03 Adare Pharmaceuticals USA, Inc. Sustained release particle formulations
ITTO20120596A1 (it) * 2012-07-06 2014-01-07 Consiglio Nazionale Ricerche Procedimento e sistema per assemblare una forma di dosaggio orale, e forma di dosaggio orale
US10272033B2 (en) * 2013-05-31 2019-04-30 Universal Stabilization Technologies, Inc Polymeric compositions containing ambient-temperature stable biopharmaceuticals and methods for formulation thereof
ES2675002T3 (es) * 2014-04-08 2018-07-05 Dow Global Technologies Llc Dispersión que comprende un éter de celulosa esterificado
CA2949372C (en) 2014-06-02 2023-08-22 Teva Pharmaceutical Industries Ltd. Expandable gastroretentive dosage form
TWI535784B (zh) 2014-08-26 2016-06-01 財團法人工業技術研究院 剪切增稠配方、及包含其之複合材料
CA3023278C (en) * 2016-05-05 2019-04-30 Triastek, Inc. Controlled release dosage form
WO2018102799A1 (en) 2016-12-02 2018-06-07 Clexio Biosciences Ltd. Gastric residence system
US20180282527A1 (en) * 2017-03-30 2018-10-04 Shin-Etsu Chemical Co., Ltd. Injection molding composition containing hypromellose acetate succinate and method for producing same
BR112020000011A2 (pt) 2017-07-11 2020-07-21 Qualicaps Co., Ltd. cápsula dura entérica
WO2019111132A1 (en) 2017-12-04 2019-06-13 Clexio Biosciences Ltd. Long acting gastric residence system
CN112566668A (zh) 2018-06-22 2021-03-26 快力胶囊股份有限公司 肠溶性硬胶囊

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3186910A (en) 1962-03-08 1965-06-01 Jacob A Glassman Method for producing peroral capsules
US3228789A (en) 1962-10-22 1966-01-11 Jacob A Glassman Peroral capsules and tablets and the method for making same
FR1454013A (fr) 1965-08-18 1966-07-22 Pluripharm Mode de présentation de deux médicaments associés
NL7610038A (en) 1976-09-09 1978-03-13 Tapanahony N V Multichambered capsule for therapeutically active substances - has chambers of different solubility with contents differing quantitatively and qualitatively
WO1983001454A1 (en) 1981-10-21 1983-04-28 Smith, Charles, E. A method and composition for substrate coating
GR78492B (ru) 1982-03-26 1984-09-27 Warner Lambert Co
EG16028A (en) 1982-03-26 1986-12-30 Warner Lambert Co Apparatus and method for molding capsules
US4790881A (en) 1982-03-26 1988-12-13 Warner-Lambert Company Molded hydrophilic polymer
US4655840A (en) 1982-03-26 1987-04-07 Warner-Lambert Company Hydrophilic polymer compositions for injection molding
FR2524311A1 (fr) 1982-04-05 1983-10-07 Azalbert Gilles Gelule compartimentee aux fins d'ingestions simultanees a effets differes
US4576284A (en) 1983-12-02 1986-03-18 Warner-Lambert Company Closing of filled capsules
US4738724A (en) 1983-11-04 1988-04-19 Warner-Lambert Company Method for forming pharmaceutical capsules from starch compositions
CH661878A5 (de) 1983-11-04 1987-08-31 Warner Lambert Co Kapsel-dosierungsformen.
US4738817A (en) 1983-11-17 1988-04-19 Warner-Lambert Company Method for forming pharmaceutical capsules from hydrophilic polymers
US5082655A (en) 1984-07-23 1992-01-21 Zetachron, Inc. Pharmaceutical composition for drugs subject to supercooling
US4629621A (en) 1984-07-23 1986-12-16 Zetachron, Inc. Erodible matrix for sustained release bioactive composition
US4678516A (en) 1984-10-09 1987-07-07 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
US4764378A (en) 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
DE3612212A1 (de) 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
DE3727894A1 (de) 1987-08-21 1989-03-02 Stephan Dieter Kapsel fuer pharmazeutisch wirksame inhaltsstoffe einer droge
US5139790A (en) 1988-10-14 1992-08-18 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
US5135752A (en) 1988-10-14 1992-08-04 Zetachron, Inc. Buccal dosage form
US5244668A (en) 1988-10-14 1993-09-14 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
US5004601A (en) 1988-10-14 1991-04-02 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
WO1990012567A1 (en) 1989-04-21 1990-11-01 Moskovsky Avtomobilestroitelny Institut (Vtuz-Zil) Device for controlled dosing of active substances into an operative medium
DE4138513A1 (de) 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
WO1996010996A1 (en) 1993-07-21 1996-04-18 The University Of Kentucky Research Foundation A multicompartment hard capsule with control release properties
US5443461A (en) 1993-08-31 1995-08-22 Alza Corporation Segmented device for simultaneous delivery of multiple beneficial agents
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
DE4413350A1 (de) 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
DE19509807A1 (de) 1995-03-21 1996-09-26 Basf Ag Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen
DE9414065U1 (de) 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen
DE4431832A1 (de) * 1994-09-07 1996-03-14 Cordes Guenter Dr Arzneimittelzubereitung für ACE-Hemmer
DE19504832A1 (de) 1995-02-14 1996-08-22 Basf Ag Feste Wirkstoff-Zubereitungen
DE19504831A1 (de) 1995-02-14 1996-09-05 Basf Ag Feste Wirkstoffzubereitungen enthaltend Hydroxypropylcellulose
DE19509805A1 (de) 1995-03-21 1996-09-26 Basf Ag Transparente, schnell freisetzende Zubereitungen von nichtsteroidalen Analgetica
DE19531277A1 (de) 1995-08-25 1997-02-27 Basf Ag Verwendung von Lipiden als Hilfsmittel bei der Herstellung von festen Arzneiformen nach dem Schmelzextrusionsverfahren
JPH09165494A (ja) 1995-11-16 1997-06-24 Yuka Shell Epoxy Kk 硬化性エポキシ樹脂組成物およびその使用
WO1997033569A1 (de) * 1996-03-13 1997-09-18 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Arzneimittelzubereitung für ace-hemmer
DE19733505A1 (de) 1997-08-01 1999-02-04 Knoll Ag Schnell wirksames Analgeticum
DE19753297A1 (de) 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19753298A1 (de) 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19753300A1 (de) 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19753299A1 (de) 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19800927A1 (de) 1998-01-13 1999-07-15 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19812688A1 (de) 1998-03-23 1999-09-30 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
BR0012869A (pt) * 1999-07-30 2002-05-21 Smithkline Beecham Plc Forma de dosagem farmacêutica de componentes múltiplos
JP4840793B2 (ja) * 2000-03-23 2011-12-21 塩野義製薬株式会社 撥水性成分を配合することを特徴とする難水溶性薬物の腸溶顆粒製剤
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
PL365746A1 (en) * 2001-02-27 2005-01-10 Astrazeneca Ab Pharmaceutical formulation comprising bicalutamide
MY142179A (en) * 2002-07-25 2010-10-15 Glaxo Group Ltd Multicomponent pharmaceutical dosage form
EP1537880A4 (en) * 2002-09-11 2009-07-01 Takeda Pharmaceutical PREPARATION FOR PROLONGED RELEASE
TW200526274A (en) * 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
EP1684713A1 (en) * 2003-11-14 2006-08-02 ALZA Corporation Controlled release of topirimate in liquid dosage forms
EP1708687A1 (en) * 2004-01-16 2006-10-11 Glaxo Group Limited Encapsulation of lipid-based formulations in enteric polymers
AR048033A1 (es) 2004-03-12 2006-03-22 Smithkline Beecham Plc Composicion farmaceutica para moldear componentes que comprende copolimero de poli(met)acrilato, cubierta, conector o espaciador de capsula moldeado por inyeccion que tiene la composicion farmaceutica y forma de dosificacion farmaceutica de multicomponentes a partir de dicha composicion
JP2008535837A (ja) * 2005-04-06 2008-09-04 マリンクロッド・インコーポレイテッド マトリックスをベースとするパルス放出製剤
CN101827572A (zh) * 2007-10-15 2010-09-08 葛兰素集团有限公司 用于释放药物组合物的有板条的胶囊壳
EP2537506A1 (en) * 2007-10-15 2012-12-26 Capsugel Belgium NV Linkers for multipart dosage forms for release of one or more parmaceutical compositions, and the resulting dosage forms
EP2219624A2 (en) * 2007-11-08 2010-08-25 Glaxo Group Limited Pharmaceutical formulations

Also Published As

Publication number Publication date
CA2705285A1 (en) 2009-07-16
TW200936186A (en) 2009-09-01
KR20100096141A (ko) 2010-09-01
JP2011503048A (ja) 2011-01-27
MX2010005092A (es) 2010-05-27
AU2008346205B2 (en) 2012-07-19
CN101917978A (zh) 2010-12-15
US20110117190A1 (en) 2011-05-19
AU2008346205A1 (en) 2009-07-16
US20090148518A1 (en) 2009-06-11
WO2009087483A3 (en) 2009-10-22
EP2219624A2 (en) 2010-08-25
WO2009087483A2 (en) 2009-07-16
BRPI0820381A2 (pt) 2015-05-19

Similar Documents

Publication Publication Date Title
EA201070568A1 (ru) Фармацевтические составы
MX2010013731A (es) Cubierta de capsula de hidroxipropil celulosa.
BRPI0508342A (pt) formulações farmacêuticas
CY1118661T1 (el) Φαρμακευτικη συνθεση, φαρμακευτικη δοσολογικη μορφη, διαδικασια για την παρασκευη τους, μεθοδοι για αντιμετωπιση και χρησεις αυτων
EA201390783A1 (ru) Биоразлагаемые композиции для доставки лекарственных средств
EP1988910A4 (en) CONJUGATES OF POLYMERS CONTAINING ACRYLOYLOXYETHYLPHOSPHORYLCHOLINE AND THEIR PREPARATION
MEP31108A (en) Gastroresistant pharmaceutical formulations containing rifaximin
CY1115652T1 (el) Μορφη δοσολογιας που περιεχει δυο δραστικα φαρμακευτικα συστατικα μειγματος σε διαφορετικες φυσικες μορφες
BRPI0916877A2 (pt) composição farmacêutica e administração da mesma
EA201001577A1 (ru) Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения
MXPA06000791A (es) Formulaciones farmaceuticas.
BRPI0707612B8 (pt) vaso lacrado e formulações líquidas contidas no mesmo
WO2002060385A3 (en) Pharmaceutical formulation
WO2009088414A3 (en) Oral pharmaceutical dosage forms
MX2011000884A (es) Medicamento apetecible de administracion oral bajo forma solida.
ATE383859T1 (de) Direkt komprimierbare pharmazeutische zusammensetzung für die orale verabreichung von cci-779
BR112012003283A8 (pt) sal farmaceuticamente aceitável de um agente fotossensibilizante anfifílico, composição farmacêutica, produto, kit, uso de um sal farmaceuticamente aceitável de um agente fotossensibilizante anfifílico, e, método de introdução de uma molécula de medicamento no citosol de uma célula em um paciente.
FR2909867B3 (fr) Capsule remplie d'un medicament, en particulier d'un medicament inhalable.
EA201170512A1 (ru) Композиция для перорального введения
CR20110704A (es) Composiciones de dosis fija farmacéuticas sólidas que comprenden irbesartán y amilodipina, su preparación y su aplicación terapéutica
UY33076A (es) Microcápsulas de fexofenadina y composiciones que las contienen
CR9468A (es) Oblea que contiene hormonas esteroides
BRPI0509067A (pt) formulações de matriz oral que compreendem licarbazepina
WO2010109180A8 (en) Composition for the administration of polymeric drugs
BRPI0810960A2 (pt) "composto, composição farmacêutica, composição cosmética e usos de um composto e de uma composição".